Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
R&D Innovation & Pharma Drug-Device Pricing
Posted on September 26th, 2016 by Dr. Makarand Jawadekar, Ph.D in Pharma R&D
The media as of late has given a lot of coverage to the “price gouging” that pharmaceutical company Mylan engaged in with its injection device EpiPen. (more…)
How Better Data is Reducing Drug Development Costs
Posted on July 1st, 2016 by Thibault Geoui in Pharma R&D
We’ve all heard how expensive it is to bring a drug to market. Depending on who you ask, the costs have risen somewhere between USD 1.6 and 2.6 billion. (more…)
What Does the 2016 US Election Mean For Pharma?
Posted on June 28th, 2016 by Betsy Davis in Pharma R&D
With summer, the 2016 U.S. Presidential Election is now truly heating up as we have presumptive nominees from the two major political parties. While we are hearing a lot about issues like national security and immigration from Republican nominee Donald Trump and Democratic nominee Hillary Clinton, those working in the pharmaceutical industry may be wondering how their sector will be affected by the eventual winner. (more…)
A Holistic Cure for the Pharmaceutical Industry’s Ailments
Posted on June 17th, 2016 by Betsy Davis in Pharma R&D
Since the turn of the century, the pharmaceutical industry has seen dramatic changes, including dwindling drug pipelines, looming patent expirations and rising costs. (more…)
